Maarten A M Wildeman, Johan H Gibcus, Michael Hauptmann, Adrian C Begg, Marie Louise F van Velthuysen, Frank J Hoebers, Mirjam F Mastik, Ed Schuuring, Jacqueline E van der Wal, Michiel W M van den Brekel
OBJECTIVES/HYPOTHESIS: To find biomarkers associated with response to radiotherapy in laryngeal cancer that can be used together with clinical parameters to improve outcome prediction. METHODS: In this study, 26 patients irradiated for laryngeal carcinomas with a local recurrence within two years (cases) and 33 patients without recurrence (controls) were included. All pretreatment biopsies were arrayed onto a tissue array. Immunohistochemistry was performed for 13 biomarkers that were selected from the literature as potential predictors for radioresponse in head and neck (HN) cancer: Bcl-2, Bcl-xL, p16, p21, p27, p53, cyclin D1, HIF-1alpha, CA9, COX-2, EGFR, ki-67, and pRB...
February 2009: Laryngoscope